87384 Federal Register / Vol. 89, No. 212 / Friday, November 1, 2024 / Notices 

TOTAL ESTIMATED ANNUALIZED BURDEN HOURS—Continued 

Form # Form name Number of 

respondents 

Number of 

responses per 

respondent **** 

Total 

responses 

Average 

burden 

per 

response 

(in hours) 

Total 

burden 

hours 

144 ................... Adult Heart and HeartLung Status 4 Exception Extension Justification Form Medical Urgency Data ***.149 1.73 258 0.25 64.44 

145 ................... Adult Heart and HeartLung Status 4 Criteria 2 Extension Justification Form Medical Urgency Data ***.149 0.56 83 0.40 33.38 

146 ................... Adult and Pediatric Lung and HeartLung Goal Exception Form *** 149 3.72 554 0.75 415.71 

147 ................... Pediatric Lung Priority 1 Status Justification Form *** ..................... 45 1.16 52 0.33 17.23 

148 ................... Review Board Voter Form *** ........................................................... 248 22.46 5,570 0.23 1,281.12 

149 ................... Living Donor Feedback Form *** ...................................................... 207 37.73 7,810 0.13 1,015.31 

150 ................... Extra Vessels Reporting Form *** .................................................... 248 53.71 13,320 0.03 399.60 

151 ................... Non-US Transplants Reporting Form *** ......................................... 228 0.00 0 0.03 0.00 

152 ................... Discrepant HLA Typings Reporting Form *** ................................... 138 0.78 108 5.17 556.50 

153 ................... Interim Event Reporting Form *** ..................................................... 248 72.58 18,000 0.06 1,079.99 

Total .......................................................................................... 18,697 .............................. 3,184,246 .................... 851,565.51 

* The numbers of respondents and the numbers of total responses in the burden table were updated with 2023 OPTN data and reflect increases in the number of 

organ transplants and changes in the number of respondents (Transplant Centers, OPOs, and Histocompatibility Labs). 

** These two forms will not be used once the OPTN Process Data OMB package is approved and implemented. The OPTN Process Data OMB package is new 

and will be considered separate from this package. We are including these forms in this collection to avoid any lapse in approval of these forms while the OPTN 

Process Data package is being approved. 

*** These are new forms. 

**** If a form has 0.00 under average number of responses, this is an indicator that there were no submissions in calendar year 2023. 

HRSA specifically requests comments 

on (1) the necessity and utility of the 

proposed information collection for the 

proper performance of the agency’s 

functions; (2) the accuracy of the 

estimated burden; (3) ways to enhance 

the quality, utility, and clarity of the 

information to be collected; and (4) the 

use of automated collection techniques 

or other forms of information 

technology to minimize the information 

collection burden. 

Amy P. McNulty, 

Deputy Director, Executive Secretariat. 

[FR Doc. 2024–25506 Filed 10–31–24; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Eunice Kennedy Shriver National 

Institute of Child Health & Human 

Development; Notice of Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the National Advisory Child 

Health and Human Development 

Council. The meeting will be held as a 

virtual meeting and will be open to the 

public as indicated below. Individuals 

who plan to view the virtual meeting 

and need special assistance or other 

reasonable accommodations to view the 

meeting, should notify the Contact 

Person listed below in advance of the 

meeting. The meeting can be accessed 

from the NIH Videocast at the following 

link: https://videocast.nih.gov/. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Advisory 

Child Health and Human Development 

Council. 

Date: January 13–14, 2025. 

Open: January 13, 2025, 12:00 p.m. to 5:00 

p.m. 

Agenda: NICHD Director’s Report and 

other Council Business. 

Address: Eunice Kennedy Shriver National 

Institute of Child Health and Human 

Development, National Institutes of Health, 

6710B Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Closed: January 14, 2025, 9:00 a.m. to 12:15 

p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: Eunice Kennedy Shriver National 

Institute of Child Health and Human 

Development, National Institutes of Health, 

6710B Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Rebekah S. Rasooly, Ph.D., 

Director, Division of Extramural Activities, 

Eunice Kennedy Shriver National Institute of 

Child Health and Human Development, 

National Institute of Health, 6710B Rockledge 

Drive, Room: 2316, Bethesda, MD 20817. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Persons listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

Information is also available on the 

Institute’s/Center’s home page: https://

www.nichd.nih.gov/about/advisory/council, 

where an agenda and any additional 

information for the meeting will be posted 

when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.864, Population Research; 

93.865, Research for Mothers and Children; 

93.929, Center for Medical Rehabilitation 

Research; 93.209, Contraception and 

Infertility Loan Repayment Program, National 

Institutes of Health, HHS) 

Dated: October 28, 2024. 

Lauren A. Fleck, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–25420 Filed 10–31–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; Notice 

of Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the Board of Scientific 

Counselors, NIDDK. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 89, No. 212 / Friday, November 1, 2024 / Notices 87385 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be closed to the 

public as indicated below in accordance 

with the provisions set forth in section 

552b(c)(6), title 5 U.S.C., as amended for 

the review, discussion, and evaluation 

of individual grant applications 

conducted by the National Institute Of 

Diabetes And Digestive And Kidney 

Diseases, including consideration of 

personnel qualifications and 

performance, and the competence of 

individual investigators, the disclosure 

of which would constitute a clearly 

unwarranted invasion of personal 

privacy. 

Name of Committee: Board of Scientific 

Counselors, NIDDK. 

Date: April 3–4, 2025. 

Open: April 03, 2025, 10:00 a.m. to 5:00 

p.m. 

Agenda: Introductions and Overview. 

Address: National Institutes of Health, 

Building 10, 10 Center Drive, Bethesda, MD 

20892 (Virtual Meeting). 

Closed: April 04, 2025, 10:00 a.m. to 5:00 

p.m. 

Agenda: To review and evaluate personal 

qualifications and performance, and 

competence of individual Investigators. 

Address: National Institutes of Health, 

Building 10, 10 Center Drive, Bethesda, MD 

20892 (Virtual Meeting). 

Contact Person: Michael W. Krause, Ph.D., 

Scientific Director, NIDDK, National Institute 

of Diabetes and Digestive and Kidney 

Diseases, National Institute of Health, 

Building 5, Room B104, Bethesda, MD 

20892–1818, (301) 402–4633, mwkrause@

helix.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 93.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS) 

Dated: October 28, 2024. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–25418 Filed 10–31–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Amended 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the Center for Scientific 

Review Special Emphasis Panel, PAR 

Panel: Transformative Research Award 

for the Include Project, November 21, 

2024, 09:00 a.m. to November 21, 2024, 

08:00 p.m., National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892, which was 

published in the Federal Register on 

October 25, 2024, FR Doc. No. 2024– 

24882, 89 FR 85222. 

This notice is being amended to 

change the Panel Name of the meeting 

from Center for Scientific Review 

Special Emphasis Panel; PAR Panel: 

Transformative Research Award for the 

Include Project to Center for Scientific 

Review Special Emphasis Panel; RFA– 

OD–22–009: Transformative Research 

Award. The meeting is closed to the 

public. 

Dated: October 28, 2024. 

Lauren A. Fleck, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–25413 Filed 10–31–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Notice of Closed Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel; 

Catalyze: Enabling Technologies. 

Date: December 4, 2024. 

Time: 2:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

Rockledge I, 6705 Rockledge Drive, Bethesda, 

MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Kristin Goltry, Ph.D., 

Scientific Review Officer, Office of Scientific 

Review/DERA, National Heart, Lung, and 

Blood Institute, National Institutes of Health, 

6705 Rockledge Drive, Room 209–B, 

Bethesda, MD 20892, (301) 435–0297, email: 

goltrykl@mail.nih.gov. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel; 

Catalyze: Product Definition. 

Date: December 5, 2024. 

Time: 11:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

Rockledge I, 6705 Rockledge Drive, Bethesda, 

MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Kristin Goltry, Ph.D., 

Scientific Review Officer, Office of Scientific 

Review/DERA, National Heart, Lung, and 

Blood Institute, National Institutes of Health, 

6705 Rockledge Drive, Room 209–B, 

Bethesda, MD 20892, (301) 435–0297, email: 

goltrykl@mail.nih.gov. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel; 

T32 Diversity Training Grant Applications 

Review Meeting. 

Date: December 6, 2024. 

Time: 11:00 a.m. to 1:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

Rockledge I, 6705 Rockledge Drive, Bethesda, 

MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Nawazish Ali Naqvi, 

Scientific Review Officer, Office of Scientific 

Review/DERA, National Heart, Lung and 

Blood Institute, National Institutes of Health, 

6705 Rockledge Drive, Room 208–Y, 

Bethesda, MD 20892, (301) 827–7911, email: 

nawazish.naqvi@nih.gov. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel; 

NHLBI Institutional Training T32 Member 

Conflict SEP. 

Date: December 9, 2024. 

Time: 10:00 a.m. to 2:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

Rockledge I, 6705 Rockledge Drive, Bethesda, 

MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Cynthia D. Anderson, 

Ph.D., Scientific Review Officer, Office of 

Scientific Review/DERA, National Heart, 

Lung, and Blood Institute, National Institutes 

Health, 6705 Rockledge Drive, Room 207–E, 

Bethesda, MD 20892, email: 

cynthia.anderson@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.233, National Center for 

Sleep Disorders Research; 93.837, Heart and 

Vascular Diseases Research; 93.838, Lung 

Diseases Research; 93.839, Blood Diseases 

and Resources Research, National Institutes 

of Health, HHS) 

Dated: October 29, 2024. 

Bruce A. George, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–25463 Filed 10–31–24; 8:45 am] 

BILLING CODE 4140–01–P 


khammond on DSKJM1Z7X2PROD with NOTICES